🇺🇸 FDA
Patent

US 7557096

Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

granted A61KA61K31/661A61P

Quick answer

US patent 7557096 (Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof) held by ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/661, A61P, A61P31/04, A61P31/10